Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 4, 1999, Pages 1269-1273

  Shijubo, Noriharu ^a,b   Uede, Toshimitsu ^a,b   Kon, Shigeyuki ^a,b   Maeda, Masahiro ^a,b   Segawa, Tatsuya ^a,b   Imada, Akihiro ^a,b   Hirasawa, Michio ^a,b   Abe, Shosaku ^a,b  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Immuno Biological Laboratories Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; OSTEOPONTIN; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

EID: 0032826888     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.4.9807094     Document Type: Article

References (30)

1. Folkman, J., K. Whatson, D. Ingber, and D. Hanahan. 1989. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58-61.
2. Weidner, N., J. P. Semple, W. R. Welch, and J. Folkman. 1991. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med. 324:1-8.
3. Macchiarini, P., G. M. Fontanini, M. J. Hardin, F. Squartini, and G. A. Angeletti. 1992. Relation of neovascularization to metastasis of non-small cell lung cancer. Lancet 340:145-146.
4. Yuan, A,. P. C. Yang, C. J. Yu, Y. C. Lee, Y. T. Yao, C. L. Chen, L. N. Lee, S. H. Kuo, and K. T. Luh. 1995. Tumor angiogenesis correlates with histologic type and metastasis in non-small-cell lung cancer. Am. J. Respir. Crit. Care Med. 152:2157-2162.
5. Fontanini, G., S. Vignati, D. Bigini, A. Mussi, M. Lucchi, S. Chine, C. A. Angeletti, and G. Bevilacqua. 1996. Recurrence and death in non-small cell lung carcinomas: a prognostic model using pathological parameters, microvessel count, and gone protein products. Clin. Cancer Res. 2:1067-1075.
6. Fontanini, G., S. Vignati, D. Bigini, M. Lucchi, A. Mussi, F. Basolo, C. Angeletti, and G. Bevilacqua. 1996. Neoangiogenesis: a putative marker of malignancy in non-small cell lung cancer (NSCLC) development. Int. J. Cancer 67:615-619.
7. Harpole, D. H., W. G. Richards, J. E. Herndon 2nd, and D. J. Sugarbaker. 1996. Angiogenesis and molecular biologic substaging in patients with stage 1 non-small cell lung cancer. Ann. Thorac. Surg. 61:1470-1476.
8. Lucchi, M., G. Fontanini, A. Mussi, S. Vignati, A. Ribechini, G. F. Menconi, G. Bevilacqua, and C. A. Angelelti. 1997. Tumor angiogenesis and biologic markers in resected stage 1 NSCLC. Eur. J. Cardiothorac. Surg. 12:535-S41.
9. Duarte, I. G., B. L. Bufkin, M. F. Pennington, A. A. Gal, C. Cohen, A. S. Kosinski, K. A. Mansour, and J. I. Miller. 1998. Angiogenesis as a predictor of survival after surgical resection for stage 1 non-small-cell lung cancer. J Thorac. Cardiovasc. Surg. 115:652-658.
10. Shibusa, T., N. Shijubo, and S. Abe. 1998. Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma. Clin. Cancer Res. 4:1483-1487.
11. Flamme, L., G. Breier, and W. Risau. 1995. Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (flk-1) are expressed during vasculogenesis and vascular differentiation in the quail embryo. Dev. Biol. 169:699-712.
12. Kevin, P. C., and S. R. Gregory. 1996. Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis. Cancer Metas. Rev. 15:165-176.
13. Fava, R., N. Olsen, G. Spencer-Green, K.-T. Yeo, B. Berse, R. Jackman, D. Senger, H. Dvorac, and L. Brown. 1994. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J. Exp. Med. 180:341-346.
14. Ohta, Y., Y. Watanabe, S. Murakami. M. Oda, Y. Hayashi, A. Nonomura, Y. Endo, and T. Sasaki. 1997. Vascular endothelial growth factor and lymph node metastasis in primary lung cancer. Br. J. Cancer 76:1041-1045.
15. Takanami, I., F. Tanaka, T. Hashizume, and S. Kodaira. 1997. Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma. Anticancer Res. 17:2811-2814.
16. Mattern, J., R. Koomagi, and M. Volm. 1997. Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density. Anticancer Res. 17:2249-2252.
17. Fontanini, G., S. Vignati, M. Lucehi, A. Mussi, A. Calcinai, L. Boldrini, S. Chine, V. Silvestri, C. A. Angeletti, F. Basolo, and G. Bevilacqua. 1997. Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression. Br. J. Cancer 75:1295-1301.
18. Senger, D. R., S. R. Ledbetter, K. P. Claffey, A. Papadopoulos-Sergiou, C. A. Peruzzi, and M. Detmar. 1996. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the αvβ3 integrin, osteopontin, and thrombin. Am. J. Pathol. 149:293-305.
19. Brown, L. F., A. Papadopoulos-Sergiou, B. Berse, E. J. Manseau, K. Tognazzi. C. A. Perruzzi, H. F. Dvorak, and D. R. Senger. Osteopontin expression and distribution in human carcinomas. Am. J. Pathol. 145:610-623.
20. Chambers, A. F., S. M. Wilson, N. Kerkvliet, F. P. O'Malley, J. F. Harris, and A. G. Casson. 1996. Osteopontin expression in lung cancer. Lung Cancer 15:311-323.
21. Gillespie, M. T., R. J. Thomas, Z. Y. Pu, H. Zhou, T. J. Martin, and D. M. Findlay. 1997. Calcitonin receptors, hone sialoprotein and osteopontin are expressed in primary breast cancers. Int. J. Cancer 73:812-815.
22. Tuck, A. B., F. P. O'Malley, H. Singhal, K. S. Tonkin, J. F. Harris, D. Bautista, and A. F. Chambers. 1997. Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas. Arch. Pathol. Lab. Med. 121:578-584.
23. Ue, T., H. Okozaki, Y. Kitadai, S. Yamamoto, W. Yasui, T. Ishikawa, and E. Tahara. 1998. Co-expression of osteopontin and CD44v9 in gastric cancer. Int. J. Cancer 9:127-132.
24. Kim, K. J. B. Li, J. Winer, M. Armanini, N. Gillett, H. S. Phillips, and N. Ferrara. 1993. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature (Lond.) 362:841-844.
25. Kondo, S., M. Asano, and H. Suzuki 1993. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody. Biochem. Biophys. Res. Commun. 194:1234-1241.
26. Uede, T., Y. Katagiri, J. Iizuka, and M. Murakami. 1997. Osteopontin, a coordinator of host defense system: a cytokine or an extracellular adhesive protein? Microbiol. Immunol. 41:641-648.
27. Yue, T. L., P. J. McKenna, E. H. Ohlstein, M. C. Farach-Carson, W. T. Butler, K. Johanson, P. McDevilt, G. Z. Feuerstein, and J. M. Stadel. 1994. Osteopontin-stimulated vascular smooth muscle cell migration is mediated by 3 integrin. Exp. Cell Res. 214:459-464.
28. Max, R., R. R. Gerritsen, P. T. Nooijen, S. L. Goodman, A. Sutter, U. Keilholz, D. J. Ruiter, and R. M. De Waal. 1997. Immunohistochemical analysis of integrin αvβ3 expression on tumor-associated vessels of human carcinomas. Int. J. Cancer 71:320-324.
29. Brooks, P. C. A. M. Montgomery, M. Rosenfeld, R. A. Reisfeld, T. Hu, G. Klier, and H. A. Cheresh. 1994. Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79:1157-1164.
30. Ruegg, C., A. Yilmaz, O. Biele, J. Bamat, P. Chaubert, and F. J. Lejeune. 1998. Evidence for the involvement of endothelial cell integrin αvβ3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma. Nat. Med. 4:408-414.